ArticleOncology letters2015
A large inflammatory myofibroblastic tumor involving both stomach and spleen: A case report and review of the literature.
Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 19 citations in OpenAlex.
- Gastric inflammatory myofibroblastic tumor in adults: a case report and literature review.Frontiers in oncology · 2026Article
- A rare splenic and pancreatic inflammatory myofibroblastic tumour with left-sided portal hypertension and gastric varices: A case report.Experimental and therapeutic medicine · 2025Article
- Gastric inflammatory myofibroblastic tumor invading the esophagus and spleen: a rare case report and literature review.The Journal of international medical research · 2025Review
- Gastric inflammatory myofibroblastic tumor: a case report.Surgical case reports · 2024Article
- Gastric inflammatory myofibroblastic tumor presented with severe anemia and inflammation: a case report.Surgical case reports · 2024Article
- A rare case of inflammatory myofibroblast tumor of the stomach successfully treated by inverted laparoscopic and endoscopic cooperative surgery.Surgical case reports · 2023Article
- An inflammatory myofibroblastic tumor of the small intestine presenting as jejunojejunal intussusception; A case report.International journal of surgery case reports · 2023Article
- Hepatic inflammatory myofibroblastic tumor: A case report.World journal of clinical cases · 2023Article
- Inflammatory myofibroblastic tumor of the spleen: a case report.Radiology case reports · 2021Article
- Inflammatory myofibroblastic tumor of the spleen: a case report and review of the literature.International journal of clinical and experimental pathology · 2019Article
- Double amplifications of CDK4 and MDM2 in a gastric inflammatory myofibroblastic tumor mimicking cancer with local invasion of the spleen and diaphragm.Cancer biology & therapy · 2018Article
- Indolent lung opacity: Ten years follow-up of pulmonary inflammatory pseudo-tumor.World journal of clinical cases · 2017Article
- Inflammatory myofibroblastic tumor of the hand: A case report.Oncology letters · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory myofibroblastic tumor (IMT) is a rare, benign neoplasm that most commonly occurs in pediatric patients; it has been described as a pseudosarcomatous proliferation of spindled myofibroblasts mixed with lymphoplasmacytic cells. IMT has been reported in a number of locations throughout the body; however, cases occurring in the gastrointestinal tract are rare and to date, no case involving both the stomach and spleen has been reported. The current study presents a case of an extremely large IMT invading both the stomach and spleen in a 50-year-old female, presenting with a three-month history of left-sided abdominal distension without abdominal pain, fever or vomiting. As the tumor had invaded the stomach and spleen, it was completely excised and concomitantly, the entire stomach and spleen were removed. Histological examination of the biopsy revealed fascicles of spindle cells in a mixed inflammatory background, with inflammatory cells that were immunopositive for vimentin, smooth muscle actin, and negative for anaplastic lymphoma kinase and CD30, confirming the diagnosis of IMT. Four months following local excision of the mass, accompanied by a total gastrectomy and splenectomy, no abdominal distension, abdominal pain, fever or vomiting were observed and no IMT recurrence was identified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.